Clinical Trials in Phoenix

Showing 6441-6460 of 16,646 trials

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

NCT05074472

This study is a first-in-human, Phase 1, open label, multicenter, dose escalation study with expansion at the RP2D, to evaluate the safety, tolerability, and preliminary efficacy of ZB131 in patients with solid tumors where prevalence of CSP expression is high. Approximately 12 to 24 patients will be enrolled in the Dose Escalation Stage; the total number of patients will depend on the dose level at which the RP2D is defined. Patients who meet the eligibility criteria during Screening will enter the treatment period. ZB131 will be given via IV every week. Patients will be treated until disease progression or unacceptable toxicities occur.

Solid Tumor, AdultPancreatic Ductal; AdenocarcinomaOvarian Serous Adenocarcinoma+2 more

ZielBio, Inc.35 participantsStarted Jan 2022

Phoenix, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States +6 more locations

COMPLETEDPhase 2< 1 mile

Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee

NCT02116972

The purpose of this study was to assess the magnitude and duration of pain relief of a single IA injection of 2 doses (16 and 32 mg) of FX006, an extended-release formulation of TCA, relative to normal saline (placebo control).

Osteoarthritis of the Knee

Pacira Pharmaceuticals, Inc310 participantsStarted Apr 2014

Anniston, Alabama, United States • Birmingham, Alabama, United States • Mobile, Alabama, United States +41 more locations

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee

Find Trials by Condition in Phoenix

A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt

A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial

V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)

Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the Hip

Growth and Tolerance of a Partially Hydrolyzed Infant Formula

Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee

Study to Compare Exposure of TA Following Administration of FX006 or TAcs in Patients With OA of the Shoulder or Hip

EPI-743 for Mitochondrial Respiratory Chain Diseases

A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis

Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain

A Study of Mirikizumab in Participants With Plaque Psoriasis

Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OA

Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular Degeneration

Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer